287 related articles for article (PubMed ID: 33784323)
1. Selective killing of homologous recombination-deficient cancer cell lines by inhibitors of the RPA:RAD52 protein-protein interaction.
Al-Mugotir M; Lovelace JJ; George J; Bessho M; Pal D; Struble L; Kolar C; Rana S; Natarajan A; Bessho T; Borgstahl GEO
PLoS One; 2021; 16(3):e0248941. PubMed ID: 33784323
[TBL] [Abstract][Full Text] [Related]
2. Replication Protein A Phosphorylation Facilitates RAD52-Dependent Homologous Recombination in BRCA-Deficient Cells.
Carley AC; Jalan M; Subramanyam S; Roy R; Borgstahl GEO; Powell SN
Mol Cell Biol; 2022 Feb; 42(2):e0052421. PubMed ID: 34928169
[TBL] [Abstract][Full Text] [Related]
3. Dynamic regulatory interactions of rad51, rad52, and replication protein-a in recombination intermediates.
Sugiyama T; Kantake N
J Mol Biol; 2009 Jul; 390(1):45-55. PubMed ID: 19445949
[TBL] [Abstract][Full Text] [Related]
4. RAD52 inactivation is synthetically lethal with deficiencies in BRCA1 and PALB2 in addition to BRCA2 through RAD51-mediated homologous recombination.
Lok BH; Carley AC; Tchang B; Powell SN
Oncogene; 2013 Jul; 32(30):3552-8. PubMed ID: 22964643
[TBL] [Abstract][Full Text] [Related]
5. The endonuclease EEPD1 mediates synthetic lethality in RAD52-depleted BRCA1 mutant breast cancer cells.
Hromas R; Kim HS; Sidhu G; Williamson E; Jaiswal A; Totterdale TA; Nole J; Lee SH; Nickoloff JA; Kong KY
Breast Cancer Res; 2017 Nov; 19(1):122. PubMed ID: 29145865
[TBL] [Abstract][Full Text] [Related]
6. Targeting BRCA1- and BRCA2-deficient cells with RAD52 small molecule inhibitors.
Huang F; Goyal N; Sullivan K; Hanamshet K; Patel M; Mazina OM; Wang CX; An WF; Spoonamore J; Metkar S; Emmitte KA; Cocklin S; Skorski T; Mazin AV
Nucleic Acids Res; 2016 May; 44(9):4189-99. PubMed ID: 26873923
[TBL] [Abstract][Full Text] [Related]
7. Small-Molecule Disruption of RAD52 Rings as a Mechanism for Precision Medicine in BRCA-Deficient Cancers.
Chandramouly G; McDevitt S; Sullivan K; Kent T; Luz A; Glickman JF; Andrake M; Skorski T; Pomerantz RT
Chem Biol; 2015 Nov; 22(11):1491-1504. PubMed ID: 26548611
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of single-stranded DNA annealing by RAD52-RPA complex.
Liang CC; Greenhough LA; Masino L; Maslen S; Bajrami I; Tuppi M; Skehel M; Taylor IA; West SC
Nature; 2024 May; 629(8012):697-703. PubMed ID: 38658755
[TBL] [Abstract][Full Text] [Related]
9. Molecular pathways: understanding the role of Rad52 in homologous recombination for therapeutic advancement.
Lok BH; Powell SN
Clin Cancer Res; 2012 Dec; 18(23):6400-6. PubMed ID: 23071261
[TBL] [Abstract][Full Text] [Related]
10. Preferential localization of hyperphosphorylated replication protein A to double-strand break repair and checkpoint complexes upon DNA damage.
Wu X; Yang Z; Liu Y; Zou Y
Biochem J; 2005 Nov; 391(Pt 3):473-80. PubMed ID: 15929725
[TBL] [Abstract][Full Text] [Related]
11. Rad52-mediated DNA annealing after Rad51-mediated DNA strand exchange promotes second ssDNA capture.
Sugiyama T; Kantake N; Wu Y; Kowalczykowski SC
EMBO J; 2006 Nov; 25(23):5539-48. PubMed ID: 17093500
[TBL] [Abstract][Full Text] [Related]
12. RPA mediates recombination repair during replication stress and is displaced from DNA by checkpoint signalling in human cells.
Sleeth KM; Sørensen CS; Issaeva N; Dziegielewski J; Bartek J; Helleday T
J Mol Biol; 2007 Oct; 373(1):38-47. PubMed ID: 17765923
[TBL] [Abstract][Full Text] [Related]
13. Rad52 inactivation is synthetically lethal with BRCA2 deficiency.
Feng Z; Scott SP; Bussen W; Sharma GG; Guo G; Pandita TK; Powell SN
Proc Natl Acad Sci U S A; 2011 Jan; 108(2):686-91. PubMed ID: 21148102
[TBL] [Abstract][Full Text] [Related]
14. Identification of a Small Molecule Inhibitor of RAD52 by Structure-Based Selection.
Sullivan K; Cramer-Morales K; McElroy DL; Ostrov DA; Haas K; Childers W; Hromas R; Skorski T
PLoS One; 2016; 11(1):e0147230. PubMed ID: 26784987
[TBL] [Abstract][Full Text] [Related]
15. Rad52 promotes second-end DNA capture in double-stranded break repair to form complement-stabilized joint molecules.
Nimonkar AV; Sica RA; Kowalczykowski SC
Proc Natl Acad Sci U S A; 2009 Mar; 106(9):3077-82. PubMed ID: 19204284
[TBL] [Abstract][Full Text] [Related]
16. Human RAD52 stimulates the RAD51-mediated homology search.
Muhammad AA; Basto C; Peterlini T; Guirouilh-Barbat J; Thomas M; Veaute X; Busso D; Lopez B; Mazon G; Le Cam E; Masson JY; Dupaigne P
Life Sci Alliance; 2024 Mar; 7(3):. PubMed ID: 38081641
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous Targeting of PARP1 and RAD52 Triggers Dual Synthetic Lethality in BRCA-Deficient Tumor Cells.
Sullivan-Reed K; Bolton-Gillespie E; Dasgupta Y; Langer S; Siciliano M; Nieborowska-Skorska M; Hanamshet K; Belyaeva EA; Bernhardy AJ; Lee J; Moore M; Zhao H; Valent P; Matlawska-Wasowska K; Müschen M; Bhatia S; Bhatia R; Johnson N; Wasik MA; Mazin AV; Skorski T
Cell Rep; 2018 Jun; 23(11):3127-3136. PubMed ID: 29898385
[TBL] [Abstract][Full Text] [Related]
18. Personalized synthetic lethality induced by targeting RAD52 in leukemias identified by gene mutation and expression profile.
Cramer-Morales K; Nieborowska-Skorska M; Scheibner K; Padget M; Irvine DA; Sliwinski T; Haas K; Lee J; Geng H; Roy D; Slupianek A; Rassool FV; Wasik MA; Childers W; Copland M; Müschen M; Civin CI; Skorski T
Blood; 2013 Aug; 122(7):1293-304. PubMed ID: 23836560
[TBL] [Abstract][Full Text] [Related]
19. A simple fluorescent assay for the discovery of protein-protein interaction inhibitors.
Al-Mugotir M; Kolar C; Vance K; Kelly DL; Natarajan A; Borgstahl GEO
Anal Biochem; 2019 Mar; 569():46-52. PubMed ID: 30707898
[TBL] [Abstract][Full Text] [Related]
20. FRET-based assays to monitor DNA binding and annealing by Rad52 recombination mediator protein.
Grimme JM; Spies M
Methods Mol Biol; 2011; 745():463-83. PubMed ID: 21660711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
